Skip to Main Content

Author Details

Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
2003
248
92
PMIDPaper TitleJournal TitlePublished Year
38041901Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival.Gynecol Oncol2024
38041901Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival.Gynecol Oncol2024
37849038Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer.Cancer Discov2024
37849038Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer.Cancer Discov2024
36123219Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate Cancer.Eur Urol2023
35766391Survival of Locally Advanced MSI-high Gastric Cancer Patients Treated With Perioperative Chemotherapy: A Retrospective Cohort Study.Ann Surg2023
36123219Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate Cancer.Eur Urol2023
37591896Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis.Nat Commun2023
37732244Deep Learning Model for Tumor Type Prediction using Targeted Clinical Genomic Sequencing Data.medRxiv2023
37890492Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers.Cancer Cell2023
37413991Immunometabolic coevolution defines unique microenvironmental niches in ccRCC.Cell Metab2023
37289003The Impact of Germline Alterations in Appendiceal Adenocarcinoma.Clin Cancer Res2023
37095257The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses.Oncogene2023
37406106Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.Clin Cancer Res2023
37084736Genomic mapping of metastatic organotropism in lung adenocarcinoma.Cancer Cell2023
36712010The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses.Res Sq2023
37078708TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy.Blood Adv2023
37014044Correction: ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer.Cancer Res2023
36493333Molecular Classification of Appendiceal Adenocarcinoma.J Clin Oncol2023
37436885Unique Genomic Alterations and Microbial Profiles Identified in Patients With Gastric Cancer of African, European, and Asian Ancestry: A Novel Path for Precision Oncology.Ann Surg2023
36611031Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers.Nat Commun2023
36993558Analysis of evolutionary dynamics and clonal architecture in prostate cancer.bioRxiv2023
36990277Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy Response.Mod Pathol2023
37503077Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors.Res Sq2023
37223888The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non-Small Cell Lung Cancer.Clin Cancer Res2023
37034672Distinct tumor architectures for metastatic colonization of the brain.bioRxiv2023
36780766Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib.Lung Cancer2023
37591896Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis.Nat Commun2023
37890492Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers.Cancer Cell2023
37503077Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors.Res Sq2023
37732244Deep Learning Model for Tumor Type Prediction using Targeted Clinical Genomic Sequencing Data.medRxiv2023
35766391Survival of Locally Advanced MSI-high Gastric Cancer Patients Treated With Perioperative Chemotherapy: A Retrospective Cohort Study.Ann Surg2023
36993558Analysis of evolutionary dynamics and clonal architecture in prostate cancer.bioRxiv2023
37289003The Impact of Germline Alterations in Appendiceal Adenocarcinoma.Clin Cancer Res2023
37084736Genomic mapping of metastatic organotropism in lung adenocarcinoma.Cancer Cell2023
36990277Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy Response.Mod Pathol2023
37014044Correction: ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer.Cancer Res2023
37413991Immunometabolic coevolution defines unique microenvironmental niches in ccRCC.Cell Metab2023
37078708TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy.Blood Adv2023
37406106Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.Clin Cancer Res2023
37436885Unique Genomic Alterations and Microbial Profiles Identified in Patients With Gastric Cancer of African, European, and Asian Ancestry: A Novel Path for Precision Oncology.Ann Surg2023
37034672Distinct tumor architectures for metastatic colonization of the brain.bioRxiv2023
37095257The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses.Oncogene2023
37223888The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non-Small Cell Lung Cancer.Clin Cancer Res2023
36780766Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib.Lung Cancer2023
36611031Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers.Nat Commun2023
36712010The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses.Res Sq2023
36493333Molecular Classification of Appendiceal Adenocarcinoma.J Clin Oncol2023
33214457Distinct Genomic Profiles are Associated With Conversion to Resection and Survival in Patients With Initially Unresectable Colorectal Liver Metastases Treated With Systemic and Hepatic Artery Chemotherapy.Ann Surg2022
36048199Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort.Cancer Discov2022
  • 1 - 50 of 496

Recommended Authors

Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 41
Erasmus MC Cancer Institute
Career Start Year 2017
Number of shared co-authors 4
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 9
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 22
Institute for Cancer Research, Oslo University Hospital
Career Start Year 2014
Number of shared co-authors 8
University of California San Francisco
Career Start Year 2014
Number of shared co-authors 11
University of Chinese Academy of Sciences
Career Start Year 2014
Number of shared co-authors 5
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2014
Number of shared co-authors 38
Bakar Computational Health Sciences Institute, University of California san francisco
Career Start Year 2012
Number of shared co-authors 28
Broad Institute of Harvard and MIT
Career Start Year 2010
Number of shared co-authors 26
Washington University
Career Start Year 2009
Number of shared co-authors 63
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 9
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 27
University of Basel
Career Start Year 2008
Number of shared co-authors 36
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 27
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 11
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 29
Novartis Institutes for BioMedical Research
Career Start Year 2005
Number of shared co-authors 14
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 10
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 12
Broad Institute of Harvard and MIT
Career Start Year 2004
Number of shared co-authors 47
University of California
Career Start Year 2003
Number of shared co-authors 6
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 27
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 22
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 56
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 7
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 7
Monash University
Career Start Year 2000
Number of shared co-authors 23
Uppsala University
Career Start Year 1999
Number of shared co-authors 3
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 7

Collaborators

Co-authored papers 67
Broad Institute of MIT and Harvard
Co-authored papers 52
Memorial Sloan Kettering Cancer Center
Co-authored papers 41
The University of Texas MD Anderson Cancer Center
Co-authored papers 41
Memorial Sloan Kettering Cancer Center
Co-authored papers 40
Memorial Sloan Kettering Cancer Center
Co-authored papers 38
Memorial Sloan Kettering Cancer Center
Co-authored papers 36
Memorial Sloan Kettering Cancer Center
Co-authored papers 27
Memorial Sloan Kettering Cancer Center
Co-authored papers 25
Memorial Sloan Kettering Cancer Center
Co-authored papers 23
Memorial Sloan Kettering Cancer Center
Co-authored papers 23
Memorial Sloan Kettering Cancer Center
Co-authored papers 23
Oncology R&D
Co-authored papers 20
Memorial Sloan Kettering Cancer Center
Co-authored papers 19
Memorial Sloan Kettering Cancer Center
Co-authored papers 15
University of Lausanne (UNIL)
Co-authored papers 14
Co-authored papers 14
Co-authored papers 13
Co-authored papers 13
Co-authored papers 13
Dana-Farber Cancer Institute
Co-authored papers 13
Memorial Sloan Kettering Cancer Center
Co-authored papers 12
Co-authored papers 12
Memorial Sloan Kettering Cancer Center
Co-authored papers 11
Fred Hutchinson Cancer Center
Co-authored papers 11
Memorial Sloan Kettering Cancer Center
Co-authored papers 11
Co-authored papers 10
Co-authored papers 10
Perlmutter Cancer Center
Co-authored papers 10
Cleveland Clinic.
Co-authored papers 10